GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Shineway Pharmaceutical Group Ltd (OTCPK:CSWYF) » Definitions » Interest Expense

China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Interest Expense : $-0.4 Mil (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is China Shineway Pharmaceutical Group Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. China Shineway Pharmaceutical Group's interest expense for the six months ended in Dec. 2023 was $ -0.4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.4 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. China Shineway Pharmaceutical Group's Operating Income for the six months ended in Dec. 2023 was $ 53.7 Mil. China Shineway Pharmaceutical Group's Interest Expense for the six months ended in Dec. 2023 was $ -0.4 Mil. China Shineway Pharmaceutical Group's Interest Coverage for the quarter that ended in Dec. 2023 was 149.53. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


China Shineway Pharmaceutical Group Interest Expense Historical Data

The historical data trend for China Shineway Pharmaceutical Group's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Shineway Pharmaceutical Group Interest Expense Chart

China Shineway Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.38 -2.54 -0.20 -0.09 -0.38

China Shineway Pharmaceutical Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 -0.05 -0.04 -0.02 -0.36

China Shineway Pharmaceutical Group Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Shineway Pharmaceutical Group  (OTCPK:CSWYF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

China Shineway Pharmaceutical Group's Interest Expense for the six months ended in Dec. 2023 was $-0.4 Mil. Its Operating Income for the six months ended in Dec. 2023 was $53.7 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was $0.1 Mil.

China Shineway Pharmaceutical Group's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2023 )/Interest Expense (Q: Dec. 2023 )
=-1*53.681/-0.359
=149.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. China Shineway Pharmaceutical Group Ltd has enough cash to cover all of its debt. Its financial situation is stable.


China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Business Description

Traded in Other Exchanges
Address
Luan Cheng, Hebei Province, Shijiazhuang, CHN
China Shineway Pharmaceutical Group Ltd is an investment holding company in the People's Republic of China. Principally, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, and others of which injection generates maximum revenue to the company.

China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Headlines